Leonard S. Schleifer
2020
In 2020, Leonard S. Schleifer earned a total compensation of $135.4M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 531% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,567,714 |
|---|---|
| Salary | $1,480,119 |
| Stock Awards | $130,000,032 |
| Other | $302,256 |
| Total | $135,350,121 |
Schleifer received $130M in stock awards, accounting for 96% of the total pay in 2020.
Schleifer also received $3.6M in non-equity incentive plan, $1.5M in salary and $302.3K in other compensation.
Rankings
In 2020, Leonard S. Schleifer's compensation ranked 16th out of 13,090 executives tracked by ExecPay. In other words, Schleifer earned more than 99.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 16 out of 13,090 | 100th |
Division Manufacturing | 3 out of 5,617 | 100th |
Major group Chemicals And Allied Products | 2 out of 2,248 | 100th |
Industry group Drugs | 2 out of 1,948 | 100th |
Industry Pharmaceutical Preparations | 1 out of 1,453 | 100th |
Source: SEC filing on April 23, 2021.
Schleifer's colleagues
We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2020.
2020
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2020
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2020
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
2020
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019